• 1
    Gout S, Tremblay PL, Huot J. Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis. 2008; 25: 335-344.
  • 2
    Tremblay PL, Huot J, Auger FA. Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions. Cancer Res. 2008; 68: 5167-5176.
  • 3
    Khatib AM, Auguste P, Fallavollita L, et al. Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol. 2005; 167: 749-759.
  • 4
    Auguste P, Fallavollita L, Wang N, Burnier J, Bikfalvi A, Brodt P. The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol. 2007; 170: 1781-1792.
  • 5
    Sturm JW, Magdeburg R, Berger K, et al. Influence of TNFA on the formation of liver metastases in a syngenic mouse model. Int J Cancer. 2003; 107: 11-21.
  • 6
    Aarons CB, Bajenova O, Andrews C, et al. Carcinoembryonic antigen-stimulated THP-1 macrophages activate endothelial cells and increase cell-cell adhesion of colorectal cancer cells. Clin Exp Metastasis. 2007; 24: 201-209.
  • 7
    Thomas SN, Zhu F, Schnaar RL, Alves CS, Konstantopoulos K. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem. 2008; 283: 15647-15655.
  • 8
    Roselli M, Guadagni F, Martini F, et al. Association between serum carcinoembryonic antigen and endothelial cell adhesion molecules in colorectal cancer. Oncology. 2003; 65: 132-138.
  • 9
    Neumaier M, Gerhard M, Wagener C. Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene. 1995; 159: 43-47.
  • 10
    Mori M, Mimori K, Ueo H, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer. 1996; 68: 739-743.
  • 11
    Guadagni F, Roselli M, Cosimelli M, et al. Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation. Int J Cancer. 1997; 72: 949-954.
  • 12
    Wanebo HJ, Rao B, Pinsky CM, et al. Preoperative carcinoembryonic antigen levels as a prognostic indicator of colorectal cancer. N Engl J Med. 1978; 299: 448-451.
  • 13
    Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007; 253: 180-204.
  • 14
    Wharton RQ, Jonas SK, Glover C, et al. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using 2 reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res. 1999; 5: 4158-4163.
  • 15
    Guadagni F, Kantor J, Aloe S, et al. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Cancer Res. 2001; 61: 2523-2532.
  • 16
    Wang JY, Wu CH, Lu CY, et al. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. World J Surg. 2006; 30: 1007-1013.
  • 17
    Sadahiro S, Suzuki T, Maeda Y, et al. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer. Ann Surg Oncol. 2007; 14: 1092-1098.
  • 18
    Wang JY, Lin SR, Wu CH, et al. Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels. Clin Cancer Res. 2007; 13: 2406-2413.
  • 19
    Gervasoni A, Monasterio Munoz RM, et al. Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett. 2008; 263: 267-279.
  • 20
    Sadahiro S, Suzuki T, Tokunaga N, et al. Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase-polymerase chain reaction. Cancer. 2001; 92: 1251-1258.
  • 21
    Hebbar M, Revillion F, Louchez MM, Fournier C, Bonneterre J, Peyrat JP. Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients. Clin Cancer Res. 1999; 5: 1427-1433.
  • 22
    Shaker OG, Ay El-Deen MA, Abd El-Rahim MT, Talaat RM. Gene expression of E-selectin in tissue and its protein level in serum of breast cancer patients. Tumori. 2006; 92: 524-530.